Protective effects of calcium channel blockers on hydrogen peroxide induced increases in endothelial permeability. 1990

Y Yamada, and M Yokota, and T Furumichi, and H Furui, and K Yamauchi, and H Saito
Nagoya University School of Medicine, Japan.

OBJECTIVE The aim was to examine the effects of calcium channel blockers on the permeability of endothelial cells and to determine whether these agents could protect against increases in endothelial permeability induced by hydrogen peroxide (H2O2). METHODS Endothelial cells were cultured on collagen coated micropore filters. When they were confluent on the filter, albumin transfer and electrical resistance across the endothelial monolayers were measured. METHODS Endothelial cells were obtained from human umbilical veins. The cells at the 2nd to 4th passage were used for the experiments. RESULTS Nilvadipine (10(-8) M) suppressed endothelial albumin transfer by 37.2% (p less than 0.01) and enhanced electrical resistance by 25.8% (p less than 0.01), whereas nicardipine (10(-7) M), diltiazem (10(-7) M), and verapamil (10(-7) M) had no significant effect on either variable without the addition of H2O2. H2O2(0.2 mM) increased albumin transfer by 164% (p less than 0.01) and reduced electrical resistance by 67% (p less than 0.01) across endothelial monolayers without endothelial cell lysis. Nilvadipine (10(-8) M) and nicardipine (10(-7) M) inhibited the (0.2 mM) H2O2 induced increases in endothelial albumin transfer and decreases in electrical resistance more strongly than diltiazem and verapamil, although all of these agents significantly reduced such injury. CONCLUSIONS Nilvadipine is a potent inhibitor of endothelial permeability and of hydrogen peroxide induced increases in permeability.

UI MeSH Term Description Entries
D009529 Nicardipine A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents. Antagonil,Cardene,Cardene I.V.,Cardene SR,Dagan,Flusemide,Lecibral,Lincil,Loxen,Lucenfal,Nicardipine Hydrochloride,Nicardipine LA,Nicardipino Ratiopharm,Nicardipino Seid,Perdipine,Ridene,Vasonase,Y-93,Hydrochloride, Nicardipine,LA, Nicardipine,Y 93,Y93
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D002199 Capillary Permeability The property of blood capillary ENDOTHELIUM that allows for the selective exchange of substances between the blood and surrounding tissues and through membranous barriers such as the BLOOD-AIR BARRIER; BLOOD-AQUEOUS BARRIER; BLOOD-BRAIN BARRIER; BLOOD-NERVE BARRIER; BLOOD-RETINAL BARRIER; and BLOOD-TESTIS BARRIER. Small lipid-soluble molecules such as carbon dioxide and oxygen move freely by diffusion. Water and water-soluble molecules cannot pass through the endothelial walls and are dependent on microscopic pores. These pores show narrow areas (TIGHT JUNCTIONS) which may limit large molecule movement. Microvascular Permeability,Permeability, Capillary,Permeability, Microvascular,Vascular Permeability,Capillary Permeabilities,Microvascular Permeabilities,Permeabilities, Capillary,Permeabilities, Microvascular,Permeabilities, Vascular,Permeability, Vascular,Vascular Permeabilities
D002463 Cell Membrane Permeability A quality of cell membranes which permits the passage of solvents and solutes into and out of cells. Permeability, Cell Membrane
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004110 Diltiazem A benzothiazepine derivative with vasodilating action due to its antagonism of the actions of CALCIUM ion on membrane functions. Aldizem,CRD-401,Cardil,Cardizem,Dilacor,Dilacor XR,Dilren,Diltiazem Hydrochloride,Diltiazem Malate,Dilzem,Tiazac,CRD 401,CRD401
D004553 Electric Conductivity The ability of a substrate to allow the passage of ELECTRONS. Electrical Conductivity,Conductivity, Electric,Conductivity, Electrical
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Y Yamada, and M Yokota, and T Furumichi, and H Furui, and K Yamauchi, and H Saito
July 2008, Archives of pharmacal research,
Y Yamada, and M Yokota, and T Furumichi, and H Furui, and K Yamauchi, and H Saito
November 1993, The Journal of pharmacology and experimental therapeutics,
Y Yamada, and M Yokota, and T Furumichi, and H Furui, and K Yamauchi, and H Saito
January 1994, Life sciences,
Y Yamada, and M Yokota, and T Furumichi, and H Furui, and K Yamauchi, and H Saito
October 1995, Biochemical pharmacology,
Y Yamada, and M Yokota, and T Furumichi, and H Furui, and K Yamauchi, and H Saito
October 1994, Drugs & aging,
Y Yamada, and M Yokota, and T Furumichi, and H Furui, and K Yamauchi, and H Saito
June 1994, Current eye research,
Y Yamada, and M Yokota, and T Furumichi, and H Furui, and K Yamauchi, and H Saito
March 1994, Experimental eye research,
Y Yamada, and M Yokota, and T Furumichi, and H Furui, and K Yamauchi, and H Saito
January 1993, Life sciences,
Y Yamada, and M Yokota, and T Furumichi, and H Furui, and K Yamauchi, and H Saito
April 1997, The American journal of physiology,
Y Yamada, and M Yokota, and T Furumichi, and H Furui, and K Yamauchi, and H Saito
March 2023, Endocrine,
Copied contents to your clipboard!